Suzhou Tianma Pharma is a leading manufacturer of pharmaceutical Intermediates, APIs, peptide related zchemicals and specialty chemicals since established in 1993.The key APIs are Citicoline, Clopidogrel.
With a broad range of organic synthesis technologies and bio-technology, Tianma Pharma set up a R&D center and five professional production sites around China. Today we have become a close partner for many multinational chemical companies and leading pharmaceutical companies by providing high quality products from lab scale through pilot trial to commercialized production.
Tianma specialty chemicals has been listed in Shenzhen Stock Exchange in July, 2010, with stock code 002453.
Nowadays, Tianma has entered into a new era of business development, and will focus more on switching itself from a traditional manufacturer to a more flexible contract service supplier, to comply with our aim to Do whatever it takes to satisfy our customers.
